AIMS: RALA is a novel 30 mer bioinspired amphipathic peptide that is showing promise for gene delivery. Here, we used RALA to deliver the FK506-binding protein like - FKBPL gene (pFKBPL) - a novel member of the immunophilin protein family. FKBPL is a secreted protein, with overexpression shown to inhibit angiogenesis, tumor growth and stemness, through a variety of intra- and extracellular signaling mechanisms. We also elucidated proangiogenic activity and stemness after utilizing RALA to deliver siRNA (siFKBPL). MATERIALS & METHODS: The RALA/pFKBPL and RALA/siFKBPL nanoparticles were characterized in terms of size, charge, stability and toxicity. Overexpression and knockdown of FKBPL was assessed in vitro and in vivo. RESULTS: RALA delivered both pFKBPL and siFKBPL with less cytotoxicity than commercially available counterparts. In vivo, RALA/pFKBPL delivery retarded tumor growth, and prolonged survival with an associated decrease in angiogenesis, while RALA/siFKBPL had no effect on tumor growth rate or survival, but resulted in an increase in angiogenesis and stemness. CONCLUSION: RALA is an effective delivery system for both FKBPL DNA and RNAi and highlights an alternative therapeutic approach to harnessing FKBPL's antiangiogenic and antistemness activity.
AIMS: RALA is a novel 30 mer bioinspired amphipathic peptide that is showing promise for gene delivery. Here, we used RALA to deliver the FK506-binding protein like - FKBPL gene (pFKBPL) - a novel member of the immunophilin protein family. FKBPL is a secreted protein, with overexpression shown to inhibit angiogenesis, tumor growth and stemness, through a variety of intra- and extracellular signaling mechanisms. We also elucidated proangiogenic activity and stemness after utilizing RALA to deliver siRNA (siFKBPL). MATERIALS & METHODS: The RALA/pFKBPL and RALA/siFKBPL nanoparticles were characterized in terms of size, charge, stability and toxicity. Overexpression and knockdown of FKBPL was assessed in vitro and in vivo. RESULTS: RALA delivered both pFKBPL and siFKBPL with less cytotoxicity than commercially available counterparts. In vivo, RALA/pFKBPL delivery retarded tumor growth, and prolonged survival with an associated decrease in angiogenesis, while RALA/siFKBPL had no effect on tumor growth rate or survival, but resulted in an increase in angiogenesis and stemness. CONCLUSION: RALA is an effective delivery system for both FKBPL DNA and RNAi and highlights an alternative therapeutic approach to harnessing FKBPL's antiangiogenic and antistemness activity.
Authors: Helen O McCarthy; Alek V Zholobenko; Yuhua Wang; Brenda Canine; Tracy Robson; David G Hirst; Arash Hatefi Journal: Int J Pharm Date: 2010-12-04 Impact factor: 5.875
Authors: Hayley D McKeen; Kerry McAlpine; Andrea Valentine; Derek J Quinn; Keeva McClelland; Christopher Byrne; Martin O'Rourke; Sheila Young; Christopher J Scott; Helen O McCarthy; David G Hirst; Tracy Robson Journal: Endocrinology Date: 2008-07-31 Impact factor: 4.736
Authors: Andrea Valentine; Martin O'Rourke; Anita Yakkundi; Jenny Worthington; Michelle Hookham; Roy Bicknell; Helen O McCarthy; Keeva McClelland; Lynn McCallum; Hayder Dyer; Hayley McKeen; David J J Waugh; Jennifer Roberts; Joanne McGregor; Graham Cotton; Iain James; Timothy Harrison; David G Hirst; Tracy Robson Journal: Clin Cancer Res Date: 2011-03-01 Impact factor: 12.531
Authors: Cian M McCrudden; John W McBride; Joanne McCaffrey; Ahlam A Ali; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy Journal: Mol Ther Nucleic Acids Date: 2016-12-31 Impact factor: 8.886
Authors: Anna Egorova; Sofia Shtykalova; Alexander Selutin; Natalia Shved; Marianna Maretina; Sergei Selkov; Vladislav Baranov; Anton Kiselev Journal: Pharmaceutics Date: 2021-02-02 Impact factor: 6.321
Authors: Michelle O'Doherty; Eoghan J Mulholland; Philip Chambers; Sreekanth Pentlavalli; Monika Ziminska; Marine J Chalanqui; Hannah M Pauly; Binulal N Sathy; Tammy H Donahue; Daniel J Kelly; Nicholas Dunne; Helen O McCarthy Journal: Nanomaterials (Basel) Date: 2020-12-07 Impact factor: 5.076
Authors: Cian M McCrudden; John W McBride; Joanne McCaffrey; Emma M McErlean; Nicholas J Dunne; Vicky L Kett; Jonathan A Coulter; Tracy Robson; Helen O McCarthy Journal: Cancer Nanotechnol Date: 2018-06-01